Virtual Investor Conferences

Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com

NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Virtual Investor Forum held on March 9th are now available for online viewing.

REGISTER NOW AT:https://bit.ly/3kZM24S

The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section.

Select companies are accepting 1x1 management meeting requests through March 14th, 2023.

March 9th

Presentation Ticker(s) VolitionRX Ltd. NYSE American: VNRX Synlogic, Inc. Nasdaq: SYBX Lisata Therapeutics, Inc. NASDAQ: LSTA InMed Pharmaceuticals Inc. NASDAQ: INM Valeo Pharma Inc. OTCQB: VPHIF | TSX: VPH Roquefort Therapeutics plc OTCQB: ROQAF | LSE: ROQ

To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

About Virtual Investor Conferences®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

Media Contact:
OTC Markets Group Inc. +1 (212) 896-4428, [email protected]

Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group 
(212) 220-2221
[email protected]